| Cle Strategic Solutions Llc | |
|
17553 Cambridge Blvd Lathrup Village MI 48076-3570 | |
| (313) 784-4795 | |
| Not Available |
| Full Name | Cle Strategic Solutions Llc |
|---|---|
| Speciality | Community/Behavioral Health |
| Location | 17553 Cambridge Blvd, Lathrup Village, Michigan |
| Authorized Official Name and Position | Christal Eason (CEO) |
| Authorized Official Contact | 3137844795 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Cle Strategic Solutions Llc 17553 Cambridge Blvd Lathrup Village MI 48076-3570 Ph: (313) 784-4795 | Cle Strategic Solutions Llc 17553 Cambridge Blvd Lathrup Village MI 48076-3570 Ph: (313) 784-4795 |
| NPI Number | 1720327927 |
|---|---|
| Provider Enumeration Date | 02/07/2013 |
| Last Update Date | 02/22/2013 |
| Medicare PECOS PAC ID | 7911152079 |
|---|---|
| Medicare Enrollment ID | O20130222000028 |
News Archive
PEPID, the top developer of clinical decision-support information and technology for healthcare professionals, has announced a partnership with the American Hospital Formulary Service, the premier provider of drug information. This partnership will put the AFHS Essentials drug information in electronic format, delivered on any mobile device or within any EMR system.
A study from Columbia University reveals that patients, who have been successfully treated with buprenorphine for opioid addiction, are at a greater risk of overdose after completion of the treatment. The study was titled, "Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder", and was published in the latest issue of The American Journal of Psychiatry. This study was funded and supported by the National Institute on Drug Abuse (NIDA) and the Agency for Healthcare Research and Quality.
Piotr Olejniczak, MD, PhD, LSU Health New Orleans Professor of Neurology and Director of the Epilepsy Center, contributed to a study of the long-term effectiveness of the first direct brain responsive neurostimulator for partial onset, or focal, seizures that cannot be controlled with medication.
In a new study published online in the open-access journal PLoS Pathogens, Dr. Vincent J. Munster, of Erasmus Medical Center, Rotterdam, and colleagues identify new host species for avian influenza A virus (H5N1) and provide important information on the distinctions between the ecology and epidemiology of various global strains of the virus.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720327927 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 251S00000X | Community/behavioral Health | 6801080517 (Michigan) | Primary |
| Provider Name | Christal L Eason |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1790924470 PECOS PAC ID: 6800041872 Enrollment ID: I20130222000182 |
News Archive
PEPID, the top developer of clinical decision-support information and technology for healthcare professionals, has announced a partnership with the American Hospital Formulary Service, the premier provider of drug information. This partnership will put the AFHS Essentials drug information in electronic format, delivered on any mobile device or within any EMR system.
A study from Columbia University reveals that patients, who have been successfully treated with buprenorphine for opioid addiction, are at a greater risk of overdose after completion of the treatment. The study was titled, "Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder", and was published in the latest issue of The American Journal of Psychiatry. This study was funded and supported by the National Institute on Drug Abuse (NIDA) and the Agency for Healthcare Research and Quality.
Piotr Olejniczak, MD, PhD, LSU Health New Orleans Professor of Neurology and Director of the Epilepsy Center, contributed to a study of the long-term effectiveness of the first direct brain responsive neurostimulator for partial onset, or focal, seizures that cannot be controlled with medication.
In a new study published online in the open-access journal PLoS Pathogens, Dr. Vincent J. Munster, of Erasmus Medical Center, Rotterdam, and colleagues identify new host species for avian influenza A virus (H5N1) and provide important information on the distinctions between the ecology and epidemiology of various global strains of the virus.
› Verified 8 days ago
News Archive
PEPID, the top developer of clinical decision-support information and technology for healthcare professionals, has announced a partnership with the American Hospital Formulary Service, the premier provider of drug information. This partnership will put the AFHS Essentials drug information in electronic format, delivered on any mobile device or within any EMR system.
A study from Columbia University reveals that patients, who have been successfully treated with buprenorphine for opioid addiction, are at a greater risk of overdose after completion of the treatment. The study was titled, "Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder", and was published in the latest issue of The American Journal of Psychiatry. This study was funded and supported by the National Institute on Drug Abuse (NIDA) and the Agency for Healthcare Research and Quality.
Piotr Olejniczak, MD, PhD, LSU Health New Orleans Professor of Neurology and Director of the Epilepsy Center, contributed to a study of the long-term effectiveness of the first direct brain responsive neurostimulator for partial onset, or focal, seizures that cannot be controlled with medication.
In a new study published online in the open-access journal PLoS Pathogens, Dr. Vincent J. Munster, of Erasmus Medical Center, Rotterdam, and colleagues identify new host species for avian influenza A virus (H5N1) and provide important information on the distinctions between the ecology and epidemiology of various global strains of the virus.
› Verified 8 days ago
Jamie L Bodenhafer Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 17657 Avilla Blvd, Lathrup Village, MI 48076 Phone: 248-259-3527 | |
Psych To Site Wellness Program Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 28440 Southfield Rd, Lathrup Village, MI 48076 Phone: 248-557-4420 | |
Stop The Violence Prevention Outreach Program Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 28820 Southfield Rd Ste 124, Lathrup Village, MI 48076 Phone: 313-221-3000 Fax: 844-500-0445 | |
Thomas Psychological Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 27375 Bloomfield Dr, Lathrup Village, MI 48076 Phone: 248-217-5769 | |
American Institute Of Neurological Disorders Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 18535 W 12 Mile Rd, Suite A, Lathrup Village, MI 48076 Phone: 248-552-3734 Fax: 248-552-3736 | |
Adult & Family Counseling Services, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 27350 Southfield Rd, Lathrup Village, MI 48076 Phone: 248-219-2920 Fax: 248-541-4341 | |
Cle Strategic Solutions Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 17553 Cambridge Blvd, Lathrup Village, MI 48076 Phone: 313-784-4795 |